Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial-Reference-Cited by-同舟云学术

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Published:2016-09 Issue:9 Volume:4 Page:699-707
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Gonem Sherif,Berair Rachid,Singapuri Amisha,Hartley Ruth,Laurencin Marie F M,Bacher Gerald,Holzhauer Björn,Bourne Michelle,Mistry Vijay,Pavord Ian D,Mansur Adel H,Wardlaw Andrew J,Siddiqui Salman H,Kay Richard A,Brightling Christopher E

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. Asthma phenotypes: the evolution from clinical to molecular approaches;Wenzel;Nat Med,2012

2. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial;Green;Lancet,2002

3. Mepolizumab and exacerbations of refractory eosinophilic asthma;Haldar;N Engl J Med,2009

4. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012

5. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study;Castro;Lancet Respir Med,2014

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma;PLOS ONE;2024-07-25

2. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons;Cells;2024-02-23

3. Personalized Medicine in Severe Asthma: From Biomarkers to Biologics;International Journal of Molecular Sciences;2023-12-22

4. Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma;2023-11-15

5. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential;Experimental & Molecular Medicine;2023-11-01